Yujuan Zhou

7.2k total citations · 5 hit papers
72 papers, 4.6k citations indexed

About

Yujuan Zhou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yujuan Zhou has authored 72 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 31 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Yujuan Zhou's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (13 papers) and MicroRNA in disease regulation (8 papers). Yujuan Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (13 papers) and MicroRNA in disease regulation (8 papers). Yujuan Zhou collaborates with scholars based in China, United States and Saudi Arabia. Yujuan Zhou's co-authors include Qianjin Liao, Linda Oyang, Longzheng Xia, Shiming Tan, Yanyan Tang, Min Su, Jinguan Lin, Zhaoyang Zeng, Wei Xiong and Guiyuan Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yujuan Zhou

71 papers receiving 4.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The cancer metabolic reprogramming and immune response

2021 799 citations Longzheng Xia, Linda Oyang et al. Molecular Cancer profile →
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

2021 304 citations Yunhua Chen, Xianjie Jiang et al. Molecular Cancer profile →
Single‐cell RNA sequencing in cancer research

2021 234 citations Peng Miao, Fang Xiong et al. profile →
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

2023 121 citations Xuemeng Xu, Peng Qiu et al. Experimental & Molecular Medicine profile →
Endoplasmic reticulum stress—a key guardian in cancer

2024 62 citations Wenlong Zhang, Yidan Shi et al. Cell Death Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yujuan Zhou China	34	3.0k	2.0k	1.1k	829	560	72	4.6k
Jeff Holst Australia	37	3.0k 1.0×	1.5k 0.8×	987 0.9×	827 1.0×	407 0.7×	79	4.8k
Junnian Zheng China	38	3.6k 1.2×	1.7k 0.9×	1.9k 1.8×	1.2k 1.5×	629 1.1×	201	5.8k
Ivano Amelio Italy	33	2.9k 1.0×	1.8k 0.9×	1.4k 1.4×	505 0.6×	437 0.8×	84	4.7k
Guoguang Ying China	36	4.0k 1.3×	2.7k 1.4×	759 0.7×	590 0.7×	692 1.2×	88	5.1k
Rongcheng Luo China	35	2.4k 0.8×	1.3k 0.7×	1.1k 1.0×	502 0.6×	686 1.2×	207	4.2k
Muzafar A. Macha India	35	2.4k 0.8×	1.2k 0.6×	1.2k 1.1×	508 0.6×	419 0.7×	90	4.0k
Fangyu Zhao China	42	3.7k 1.2×	2.8k 1.4×	1.3k 1.2×	571 0.7×	633 1.1×	124	5.5k
Cristian Rodriguez‐Aguayo United States	39	3.7k 1.2×	2.3k 1.2×	890 0.8×	545 0.7×	306 0.5×	101	5.1k
Chunhong Yan United States	38	3.0k 1.0×	1.4k 0.7×	1.1k 1.0×	428 0.5×	791 1.4×	106	4.8k
Ping Wei China	39	4.4k 1.5×	2.8k 1.4×	1.2k 1.1×	743 0.9×	583 1.0×	111	5.9k

Countries citing papers authored by Yujuan Zhou

Since Specialization

Citations

This map shows the geographic impact of Yujuan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujuan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujuan Zhou more than expected).

Fields of papers citing papers by Yujuan Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujuan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujuan Zhou. The network helps show where Yujuan Zhou may publish in the future.

Co-authorship network of co-authors of Yujuan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yujuan Zhou. A scholar is included among the top collaborators of Yujuan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujuan Zhou. Yujuan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Lin‐Quan, Sai-Lan Liu, Muh‐Hwa Yang, et al.. (2025). GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study. Clinical Cancer Research. 31(16). 3424–3432.

Qiu, Peng, Xuemeng Xu, Wenlong Zhang, et al.. (2025). Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance. International Journal of Biological Sciences. 21(7). 2991–3010. 3 indexed citations

Miao, Peng, Shan Zhang, Pan Wu, et al.. (2025). Circular RNA circCLASP2 promotes nasopharyngeal carcinoma progression through binding to DHX9 to enhance PCMT1 translation. Molecular Cancer. 24(1). 67–67. 7 indexed citations

Jiang, Xianjie, Qiu Peng, Mingjing Peng, et al.. (2024). Cellular metabolism: A key player in cancer ferroptosis. Cancer Communications. 44(2). 185–204. 36 indexed citations

Zhang, Wenlong, Yidan Shi, Linda Oyang, et al.. (2024). Endoplasmic reticulum stress—a key guardian in cancer. Cell Death Discovery. 10(1). 343–343. 62 indexed citations breakdown →

Xia, Longzheng, Jinguan Lin, Mingjing Peng, et al.. (2024). Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination. International Journal of Biological Sciences. 20(4). 1125–1141. 8 indexed citations

Shi, Jingchun, Xiang Li, Yan Y. Lam, et al.. (2024). A Novel Multiple-Network Analysis Integrating Metabolomics and Pharmacology for Mechanism Study of Medicine: A Case Study of CDD-2101 Against Constipation. Journal of Analysis and Testing. 8(4). 415–430. 2 indexed citations

Xu, Xuemeng, Peng Qiu, Xianjie Jiang, et al.. (2023). Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Experimental & Molecular Medicine. 55(7). 1357–1370. 121 indexed citations breakdown →

Qiu, Peng, Yujuan Zhou, Linda Oyang, et al.. (2021). Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. Molecular Therapy. 30(3). 1018–1035. 44 indexed citations

10.

Tian, Zhi, Xiaofang Guo, Qianjin Liao, et al.. (2021). Co-inhibition of CD73 and ADORA2B Improves Long-Term Cigarette Smoke Induced Lung Injury. Frontiers in Physiology. 12. 614330–614330. 5 indexed citations

11.

Zhong, Yu, Liting Yang, Fang Xiong, et al.. (2021). Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc. Signal Transduction and Targeted Therapy. 6(1). 240–240. 60 indexed citations

12.

Ren, Daixi, Yuze Hua, Boyao Yu, et al.. (2020). Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Molecular Cancer. 19(1). 19–19. 218 indexed citations

13.

Bin, Jie, Shaolin Nie, Yingbin Hu, et al.. (2020). Long noncoding RNA EPB41L4A‐AS1 functions as an oncogene by regulating the Rho/ROCK pathway in colorectal cancer. Journal of Cellular Physiology. 236(1). 523–535. 28 indexed citations

14.

Han, Yaqian, Feng Liu, Yujuan Zhou, et al.. (2020). Radiosensitivity Effect of Epidermal Growth Factor Receptor Nanoparticles on Head and Neck Squamous Cell Carcinoma. Journal of Nanoscience and Nanotechnology. 20(10). 6013–6018. 2 indexed citations

15.

Tan, Shiming, Pin Yi, Heran Wang, et al.. (2020). RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer. Frontiers in Oncology. 10. 649–649. 21 indexed citations

16.

Liao, Xia, Juan Lin, Jian Su, et al.. (2019). Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition. SHILAP Revista de lepidopterología. 2 indexed citations

17.

Liu, Tongtong, Xuanchen Liu, Li Liu, et al.. (2019). Protein chip and bioinformatic analyses of differentially expressed proteins involved in the effect of hydrogen-rich water on myocardial ischemia-reperfusion injury. International Journal of Medical Sciences. 16(9). 1254–1259. 6 indexed citations

18.

Zhou, Yujuan, Fang Xie, Shaozhi Fu, et al.. (2018). In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells. PLoS ONE. 13(7). e0200845–e0200845. 26 indexed citations

19.

Zhou, Yujuan, Qianjin Liao, Xiayu Li, et al.. (2016). HYOU1, Regulated by LPLUNC1, Is Up-Regulated in Nasopharyngeal Carcinoma and Associated with Poor Prognosis. Journal of Cancer. 7(4). 367–376. 47 indexed citations

20.

Zhou, Yujuan, Jian Su, Ling Shi, Qianjin Liao, & Qi Su. (2012). DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion. Oncology Reports. 29(2). 605–612. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact